AstraZeneca and UK MRC in "new era" of pharma/academic collaboration
This article was originally published in Scrip
Executive Summary
AstraZeneca and MRC Technology, the commercialisation company for the UK's Medical Research Council (MRC), have entered a new strategic collaboration to share access to their compound collections in a bid to discover potential new medicines.